Name
RF7-03: ESR1m ctDNA dynamics from SERENA-6: phase 3 trial of camizestrant + CDK4/6i for emergent ESR1 mutations during 1L endocrine therapy before progression in HR+/HER2- advanced breast cancer patients - Commentary: Adam Brufsky, MD, PhD
Date & Time
Wednesday, December 3, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL